Non-Healing Wounds

HOW TO HEAL NON-HEALING WOUNDS
WITH ENLUXTRA
ADAPTIVE MOISTURE CONTROL WOUND DRESSING

Below is a case of a chronic wound, stalled for many years.

An 87-year-old Korean War veteran, a diabetic with multiple co-morbidities and partial amputations on both feet had suffered from bilateral VLUs for more than 10 years. The Enluxtra dressing treatment lasted 9 weeks and resulted in significant progress towards healing of wounds previously unresponsive to all other treatments and surgical interventions, including revascularization procedures.

Right leg: previously stalled for 10+ years VLU has completely closed in 9 weeks.

Left medial previously stalled for 10+ years VLU is significantly reduced in size and cleared of non-vital tissues. The healing process is evident as indicated by the presence of granulation tissues and healthy wound edges.

Chronic pressure injury of 12-year duration healed in 4.5 months:

Enluxtra is already adopted by leading hospitals such as UCSF Medical Center, San Francisco General Hospital and San Francisco VA, Baylor Health, Advocate Health, as well as many other health systems throughout the US.
Enluxtra has been proven successful on more than 100,000 of the most complex, "train wreck" wounds of various etiologies, drainage levels and types, including diabetic ulcers, pressure injuries, post-operative wounds with complications, radiation burns, as well as many others.

PROFESSIONAL OPINION

Patient: "Much faster healing with fewer dressing changes"

WHAT ABOUT MONEY?

ENLUXTRA is not expensive, fits under standard A-series HCPCS codes (A6196–A6197), distributed nationwide through Medline, McKesson, Cardinal Health, and other leading medical distributors.

Covered for exuding wounds, up to 30 dressings per month.
LIST OF DISTRIBUTORS

Any wound care provider, home health agency or medical facility in the US may buy Enluxtra at the direct manufacturer's price at our
ONLINE STORE

ENLUXTRA ECONOMICS IN HOME HEALTH:

Pressure injury:

Case: Pressure injury posterior thigh
Female, age 84
Non-ambulatory, wheelchair-bound for mobility.
Co-morbidities: diabetes, atrial fibrillation, hypertension, dyslipidemia.
Cause of wound: wheel chair bar located near the posterior thigh area.

Healed in 6 weeks:
11 RN visits, 10 Enluxtra 4x4 Dressings.
40% wound area reduction in first 30 days

Dressings : total: $55*
via direct purchase at
https://enluxtradirect.com/
*Prices in Medline, McKesson and other catalogs may be different

HHA total visit costs ($120 per visit): total: $1,320

Per finalized 2026 Home Health Prospective Payment System (HH PPS) rates, the base payment for two 30-day periods is $2,038 x 2 = $4,076
Estimated Case-Mix Weight - 1.5
Total payment $6,114

ENLUXTRA Supports Cost Efficiency Across the Continuum of Care

Fewer dressing changes

Extended wear time helps reduce visit frequency and staff workload

Lower dressing utilization
High absorbency and adaptability reduce the total number of dressings required per episode
Reduced reliance on adjunctive topicals
Supports autolytic debridement and moisture balance without routine use of costly enzymatic agents
Optimized inventory management
Consolidates multiple product needs into one solution, with potential inventory cost reduction of up to 30%
Streamlined protocols and documentation
Simplifies product selection and care pathways, reducing variability and administrative burden
More predictable healing trajectories
Consistent moisture balance supports stable wound conditions between visits

AND MORE...

WHY DOES IT WORK?

Why does Enluxtra Wound Dressing work well even in most extreme cases of stalled chronic wounds? Let’s examine what is required to help re-activate the healing process:

THE DIFFERENCE BETWEEN ACUTE AND CHRONIC WOUNDS

Chronic wounds typically are stalled in the inflammatory stage and do not progress to the proliferation stage.
The difference in wound healing process for normal versus chronic wounds looks like this:

WHAT NEEDS TO BE DONE TO RESUME NORMAL HEALING

To move past the inflammation stage one has to consider bacterial burden, necrotic tissue, and moisture balance of the whole wound.

Bacterial overgrowth or infection need to be eliminated.
Necrotic tissue, in most cases, needs to be debrided.
Excessive exudate, high in toxic and pro-inflammatory components, needs to be continuously removed.
Moisture balance needs to be maintained by moisturizing dry tissue and by drying wet tissue. *

* Wound care in the geriatric client.
Steve Gist, Iris Tio-Matos, Sharon Falzgraf, Shirley Cameron, and Michael Beebe Clin Interv Aging. 2009; 4: 269–287.

WHAT IS THE CHALLENGE

Wounds are non-uniform and constantly changing objects. By nature every wound has different ever-changing local areas that need different and dynamically changing care.

To move past the inflammation stage, in addition to monitoring the underlying diseases, nutritional issues and wound offloading, you have to address each wound area's ever changing needs separately, continuously and simultaneously.

ENLUXTRA

The smart feedback-driven self-regulating polymer wound dressing - ENLUXTRA - utilizes adaptive moisture control feature to respond to the dynamic, non-uniform nature of wounds. The super-absobent dressing material senses the underlying tissue's physical conditions, and is able to:

1. Adapt its local function to provide an optimal treatment for all different wound zones simultaneously;

2. Continuously evacuate non-viable tissues from the wound along with harmful bacteria, disintegrated biofilms, excessive salts, toxins, and other corrosive pro-inflammatory components.

! !
Continuous non-traumatic natural and selective wound cleansing, together with sustainable and balanced moist healing environment, helps reduce chronic inflammation and accelerate wound healing process.

HERE IS HOW THE PROCESS WORKS UNDER ENLUXTRA:

1. Enluxtra vertically absorbs and locks in excessive exudate in exuding wound zones while at the same time hydrating dry wound zones. These two simultaneous processes create a sustainable and reliable moist healing environment in the whole wound.

2. A stable moist wound environment supports effective natural autolytic debridement of non-viable tissues.
Autolytic process is selective, it affects ONLY non-viable tissues while they are present in a wound, and STOPS when the wound becomes clean, so the viable tissues are protected.

3. Unlike any other dressing, Enluxtra is able to continuously evacuate liquefied products of this process so the wound quickly becomes clean and stays clean under Enluxtra.

4. Enluxtra also evacuates harmful microorganisms from the wound by sequestering them inside the material. It chemically binds water molecules thus depriving microorganisms of the free water supply essential for their life support and multiplication. This process results in significant drainage and odor reduction.

Below is an example of an infected wound's response to Enluxtra Self-Adaptive Dressings:

The patient is an elderly female, MRSA-positive, intolerant to oral antibiotics. Enluxtra was placed for 4 days, with NO topical antibiotics used. Significant reduction of inflammation and pain was observed after just 1 dressing application.